Pathophysiology of ischemic acute kidney injury.
Sharfuddin AA, Molitoris BA.
Nat Rev Nephrol. 2011 Apr;7(4):189-200. doi: 10.1038/nrneph.2011.16. Epub 2011 Mar 1.
The Role of Hypoxia in Ischemic Chronic Kidney Disease.
Textor SC, Lerman LO.
Semin Nephrol. 2019 Nov;39(6):589-598. doi: 10.1016/j.semnephrol.2019.10.008.
Nanomedicine in kidney disease.
Bishop B, Sharma S, Scott EA.
Curr Opin Nephrol Hypertens. 2023 Jul 1;32(4):366-376. doi: 10.1097/MNH.0000000000000897. Epub 2023 May 11.
Concise review: mesenchymal stem cell treatment for ischemic kidney disease.
Zhu XY, Lerman A, Lerman LO.
Stem Cells. 2013 Sep;31(9):1731-6. doi: 10.1002/stem.1449.
Normotensive ischemic acute renal failure.
Abuelo JG.
N Engl J Med. 2007 Aug 23;357(8):797-805. doi: 10.1056/NEJMra064398.
Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics.
Berru FN, Gray SE, Thome T, Kumar RA, Salyers ZR, Coleman M, Dennis Le, O'Malley K, Ferreira LF, Berceli SA, Scali ST, Ryan TE.
Sci Rep. 2019 Oct 29;9(1):15547. doi: 10.1038/s41598-019-52107-7.
[Ischemic kidney disease].
Mustonen J, Wirta O.
Duodecim. 2006;122(2):208-14.
Post-ischemic azotemia as a partial 'brake', slowing progressive kidney disease.
Zager RA, Johnson AC, Becker K.
Nephrol Dial Transplant. 2013 Jun;28(6):1455-62. doi: 10.1093/ndt/gft040. Epub 2013 Mar 29.
Role of T cells in ischemic acute kidney injury and repair.
Lee K, Jang HR.
Korean J Intern Med. 2022 May;37(3):534-550. doi: 10.3904/kjim.2021.526. Epub 2022 Apr 28.
Epigenetic changes mediating transition to chronic kidney disease: Hypoxic memory.
Tanaka T.
Acta Physiol (Oxf). 2018 Apr;222(4):e13023. doi: 10.1111/apha.13023. Epub 2018 Jan 15.
